期刊文献+

肺炎病儿支气管肺泡灌洗液中PS水平的变化 被引量:9

CHANGES OF PS LEVEL IN BRONCHOALVEOLAR LAVAGE FLUID IN CHILDREN WITH PNEUMONIA
暂未订购
导出
摘要 目的研究肺炎病儿肺泡灌洗液中肺泡表面活性物质(PS)的变化,探讨PS在肺炎发病中的作用。方法选择肺炎病儿20例(肺炎组)和非肺炎病儿20例(对照组),应用纤维支气管镜进行肺泡灌洗,收集肺泡灌洗液,分别采用Bartlett法检测肺泡灌洗液中总磷脂(TPL)、Mason法检测饱和磷脂酰胆碱(Sat-PC)、焦酚红染色法(Pyrogallol)检测总蛋白(TP)。以Sat-PC/TPL和Sat-PC/TP比值作为判断PS活性水平的指标。结果肺炎组Sat-PC虽然较低,但与对照组比较差异无统计学意义(t=1.062,P>0.05);肺炎组Sat-PC/TPL和Sat-PC/TP较对照组明显降低,差异有显著统计学意义(t=5.383、3.938,P<0.001)。结论肺炎病儿肺泡灌洗液中PS降低,可能是导致肺炎反复或迁延不愈的重要原因之一,PS替代疗法是肺炎的一种有效的辅助治疗手段。 Objective To study the changes of the level of puImonary surfactant (PS) in bronchoalveolar lavage fluid in children with pneumonia and the role of PS in pathogenesis of the disease. Methods Twenty patients with pneumonia and 20 with non pneumonia were enrolled and alveolar wash (AS) was done via bronehofibroscopy and lavage fluid collected. Total phospholipids (TPL) was detected by Bartlett method; saturated phosphatidylcholine (Sat PC) by Manson method; and total protein (TP) by Pyrogailol. The ratio of Sat PC/TPL to Sat-PC/TP was taken as a parameter to estimate the activity of PS. Results Compared with the non pneumonia, the amount of Sat PC in the pneumonia was lower, but the difference between them was not significant (t=1. 062, P〉0.05). The ratio of Sat-PC/TPL to Sat PC/TP in the pneumonia was significantly lower than that in the non pneumonia (t= 5. 383,3. 938;P〈0. 001 ). Conclusion Decrease of PS content in bronchoalveolar lavage fluid in children with pneumonia may be one of important factors contributing recurrance or protraction of the disease. PS-substitution is an effective therapy for pneumonia.
出处 《青岛大学医学院学报》 CAS 2009年第6期542-543,546,共3页 Acta Academiae Medicinae Qingdao Universitatis
基金 深圳市科技计划项目(200606147)
关键词 肺表面活性物质相关蛋白质类 支气管肺泡灌洗液 肺炎 儿童 Pulmonary surfactant associated proteins Bronchoalveolar lavage fluid Pneumonia Child
  • 相关文献

参考文献12

二级参考文献47

  • 1宋国维,甘小庄,张艳玲,宋慧琴.肺表面活性物质对重症新生儿肺炎肺氧合功能的影响[J].中华儿科杂志,1995,33(6):336-338. 被引量:28
  • 2甘小庄,宋国维,黄伟雄,孙丽萍,马广松,李惠.肺表面活性物质功能不良的机制探讨[J].中国危重病急救医学,1996,8(3):136-138. 被引量:3
  • 3崔祥宾 王呜岐 等.实用肺脏病学[M].上海:上海科学技术出版社,1997.237.
  • 4俞森洋 张进种.现代呼吸疗法[M].北京:北京医科大学中国协和医科大学联合出版社,1994.344.
  • 5[1]Leth-Larsen R, Nordenbaek C, Tornoe I, et al. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia small star, filled[J]. Clin Immunol, 2003,108 : 29-37
  • 6[2]Crouch E,Wright JR. Surfactant proteins A and D and pulmonary host defense[J]. Annu Rev physiol,2001; 63:521-554
  • 7[3]Holmskov U. Lung surfactant proteins (SP-A and SP-D) in non-adaptive host responses to infection [J]. J Leukoc Biol,1999,66:747-752
  • 8[4]Buffer P,Schmidt B, Schikor D, et al. Surfactant protein A and D differently regulate the immune response to nonmucoid pseudomonas aeruginosa and its lipopolysaccharide[J]. Am J Respir Cell Mol Biol,2003,28: 249-256
  • 9[5]Borron P,McIntosh JC,Korfhagen TR,et al. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo[J]. Am J physiol Lung Cell Mol Physiol,2000,278 : L840-847
  • 10[6]Glasser SW,Detmer EA, Ikegami M, et al. Pneumonitis and emphysema in SP-C gene targeted mice[J]. J Biol Chem, 2003,278: 14291-14298

共引文献124

同被引文献107

引证文献9

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部